Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greene

Showing results (1061-1070 of 1,094) with videos related to

Pageof 110
Sort By:
Virology Journal|December 4, 2013
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary modelsMiguel Lacerda, Penny L Moore, Nobubelo K Ngandu, et al.
ERJ Open Research|April 20, 2023
ERS International Congress 2022: highlights from the Basic and Translational Science AssemblySara Cuevas Ocaña, Natalia El-Merhie, Merian E Kuipers, et al.
Plos Pathogens|March 13, 2020
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaquesGabriela M Webb, Jhomary Molden, Kathleen Busman-Sahay, et al.
Open Forum Infectious Diseases|October 6, 2016
Risk Factors for Influenza A(H7N9) Disease in China, a Matched Case Control Study, October 2014 to April 2015Lei Zhou, Ruiqi Ren, Jianming Ou, et al.
MMWR. Morbidity and Mortality Weekly Report|September 8, 2017
Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017James C Kile, Ruiqi Ren, Liqi Liu, et al.
Science Translational Medicine|April 9, 2010
MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaquesShelby L O'Connor, Jennifer J Lhost, Ericka A Becker, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2017
The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus MacaquesHelen L Wu, Roger W Wiseman, Colette M Hughes, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Focusing antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Pageof 110

Showing results (1061-1070 of 1,094) with videos related to

Sort By:
Pageof 110
Virology Journal|December 4, 2013
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary modelsMiguel Lacerda, Penny L Moore, Nobubelo K Ngandu, et al.
ERJ Open Research|April 20, 2023
ERS International Congress 2022: highlights from the Basic and Translational Science AssemblySara Cuevas Ocaña, Natalia El-Merhie, Merian E Kuipers, et al.
Plos Pathogens|March 13, 2020
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaquesGabriela M Webb, Jhomary Molden, Kathleen Busman-Sahay, et al.
Open Forum Infectious Diseases|October 6, 2016
Risk Factors for Influenza A(H7N9) Disease in China, a Matched Case Control Study, October 2014 to April 2015Lei Zhou, Ruiqi Ren, Jianming Ou, et al.
MMWR. Morbidity and Mortality Weekly Report|September 8, 2017
Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017James C Kile, Ruiqi Ren, Liqi Liu, et al.
Science Translational Medicine|April 9, 2010
MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaquesShelby L O'Connor, Jennifer J Lhost, Ericka A Becker, et al.
Nature Communications|February 28, 2023
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variantsJames Logue, Robert M Johnson, Nita Patel, et al.
Breast Cancer Research and Treatment|April 24, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrenceTommy A Brown, Elizabeth A Mittendorf, Diane F Hale, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2017
The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus MacaquesHelen L Wu, Roger W Wiseman, Colette M Hughes, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Focusing antibody responses to the fusion peptide in rhesus macaquesChristopher A Cottrell, Payal P Pratap, Kimberly M Cirelli, et al.
Pageof 110